Try our Advanced Search for more refined results
Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG
Case Number:
Case Type:
IPR
Status:
Institution Denied
Petitioner:
Regeneron Pharmaceuticals, Inc.
Patent Owner:
Novartis Pharma AG
Tech Center:
3700
-
Filed: July 16, 2020 00:00
Coverage
-
January 19, 2021
PTAB Denies Bid To Review Eye Shot Patent, Citing ITC Case
The Patent Trial and Appeal Board has refused to review a Novartis Pharma AG patent covering a syringe meant for eye injections, citing the "advanced stage" of a parallel case involving the same parties before the U.S. International Trade Commission.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Search PTAB cases and full-text documents.
- Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
- Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the PTAB case documentsAlready a subscriber? Click here to login
-
January 19, 2021